Prosecution Insights
Last updated: April 19, 2026

Celldex Therapeutics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18543874 ANTI-KIT ANTIBODIES AND USES THEREOF ROONEY, NORA MAUREEN 1641 Non-Final OA Dec 18, 2023
18538698 ANTI-KIT ANTIBODIES AND USES THEREOF JOHANSEN, PETER N. 1644 Final Rejection Dec 13, 2023
17720954 ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS BRISTOL, LYNN ANNE 1643 Non-Final OA Apr 14, 2022
17298071 METHODS OF USING CD27 ANTIBODIES AS CONDITIONING TREATMENT FOR ADOPTIVE CELL THERAPY TIWARI, VYOMA SHUBHAM 1634 Final Rejection May 28, 2021

Managing Celldex Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month